Robinswood Financial »

Crispr Therapeutics shares owned by Robinswood Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Robinswood Financial from 13F filings

Historical chart of Robinswood Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Robinswood Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Robinswood Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $0 0 0.00

More positions owned by Robinswood Financial

Vanguard Small-cap Growth Index Fund Etf Shares Uit Exchange Traded (VBK)
Vanguard Value Index Fund Etf Shares Uit Exchange Traded (VTV)
Vanguard Small-cap Valueindex Fund Etf Shares Uit Exchange Traded (VBR)
Ishares Msci Eafe Growthetf Uit Exchange Traded (EFG)
Vanguard Ftse Emerging Markets Index Fund Etf Shares Uit Exchange Traded (VWO)
Vanguard Growth Index Fund Etf Shares Uit Exchange Traded (VUG)
Schwab Short-term U.s. Treasury Etf Uit Exchange Traded (SCHO)
Vanguard Mortgage-backedsecurities Index Fund Etf Shares Uit Exchange Traded (VMBS)
Ishares Core U.s. Aggregate Bond Etf Uit Exchange Traded (AGG)
Avantis International Small Cap Value Etf Uit Exchange Traded (AVDV)
Dimensional International Value Etf Uit Exchange Traded (DFIV)
Ishares Core S&p Mid-capetf Uit Exchange Traded (IJH)
Schwab U.s. Tips Etf Uit Exchange Traded (SCHP)
Dimensional International Small Cap Etf Uit Exchange Traded (DFIS)
Vanguard Short-term Inflation-protected Securities Index Fund Et Uit Exchange Traded (VTIP)

View all positions for Robinswood Financial

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics